Malaria infection trial, and weeing chimpanzees
On the Naked Scientists News show: a new UK trial seeks to infect healthy people with malaria in a bid to get to grips with the dormant stage of the infection. Then, we hear how T cells could be the key to ensuring more organ transplant successes, and should we all be taking fewer flights? Also, some curious observations regarding chimpanzees and their communal toilet routines...
In this episode

01:06 - Malaria trial to deliberately infect people with parasite
Malaria trial to deliberately infect people with parasite
Andrew Duncan, University of Oxford
A group of volunteers are about to be deliberately infected with a form of malaria at the hands of researchers at the University of Oxford’s Vaccine Group who want to understand more about Plasmodium vivax - which is one common form of human malaria that can remain dormant in the liver, and then reappear even years later. To explain what they’re trying to do, and how, here’s Andrew Duncan, the doctor who’s leading the trial…
Andrew - We are planning a research study where we're taking five healthy volunteers from the United Kingdom. We are deliberately going to infect them with a species of malaria called vivax malaria to find out more about it.
Chris - Lots and lots of people, particularly people in Southeast Asia, catch this naturally, don't they? So why do you need to infect even more people with it?
Andrew - That's a very good question. You're absolutely right. It's a mosquito-borne infection, particularly common in Southeast Asia, as you say, and South America as well. The particular problem is that it causes a relapsing illness. What that means is when you get the mosquito bite that introduces the infection, it can come back months or even years later. So in Southeast Asia, where this is found, you can't really tell whether this is a new infection or a relapse—an infection that's come back. We want to develop a very controlled scenario where we can study these relapse infections closely and find out more about them.
Chris - Is it as simple as you put someone in a room with some mosquitoes that you know have got this particular form of malaria and you let the people get bitten?
Andrew - In a nutshell, yes. It has to be slightly more controlled than that. It's not a room with lots of mosquitoes whizzing around. We actually contain them in a box that's got netting on it and ask the volunteers to place their arm on the netting so that we can see the mosquitoes biting the surface of the skin. But yes, in essence, it is a mosquito bite-administered infection.
Chris - And how will you know who's got it and who hasn't?
Andrew - Once the mosquito bite has happened, we'll do daily blood tests, tracking the infection as it appears over the next week or two. What's great is that with our fancy blood test called a qPCR test, we can often detect the infection before people even develop some of the malaria symptoms you might be familiar with, like fever, muscle aches, or headache. We can treat people with a tablet to get rid of the active infection but deliberately leave the dormant form of the parasites that stay hidden in their liver. That's the bit where these sleeping parasites can reawaken in the months following to cause a relapse infection—one that comes back.
Chris - Is that the follow-up aspect of the study then? So, having made sure that people are not going to get acute, really severe malaria, you nevertheless let them develop the dormant phase and then follow that up because that's the one you're interested in. How does that happen? Why does it happen? When does it happen?
Andrew - Yeah, brilliant question. We give tablets to get rid of the active infection, leave these dormant sleeping parasites alone, and monitor people very closely for a six-month period. We're going to see them in our clinic every two weeks, and there's going to be a doctor on call 24 hours a day. If they did develop any of the symptoms such as fever or headache, they would give me a ring, and I would come to see them, take a blood test, and check to see whether they had this active reawakened infection.
Chris - And is the aim then to learn what the triggers are when this thing comes out of its dormant state in this way? Why is it doing that, and are there any markers we can look for that might give us a clue? I presume that's what you're doing this for.
Andrew - Yeah, that's the big unknown, really. In the natural world, in these countries in Southeast Asia, it's really tricky to tell the difference between a new infection from a mosquito bite and one that's coming back. They look exactly the same. So we're hoping we'll get really good insight into why these come back when they do, how the body responds when it comes back, and what the molecular processes are that happen to reawaken the parasite. It's all a big unknown. The relapse infections, we think, are responsible for the bulk of all the infections with vivax malaria that occur in the world. Understanding them to develop novel drugs, treatments, or vaccines is really key. I should say that if this study works, we will have the perfect platform to test new vaccines and new tablets. So there are two goals: one, to find out more, and two, to develop a method of testing new vaccines and drugs.
Chris - And presumably, once you're done with these people, you have got a way of clearing the dormant stage as well, so they're not destined to be wandering around with this—just like a ticking time bomb for the rest of their life.
Andrew - Yeah, thankfully, there is an additional antimalarial tablet called Primaquine that can clear the dormant parasites. What's interesting, and in keeping with all this, is no one really knows how it works. You have to take a tablet once a day for two weeks, but it is effective and will clear away the sleeping parasites that can reawaken.
Chris - Does this translate then into almost like an archive sequence of blood samples charting the infection, possibly the reactivation from the dormant state, and its retreat when you start to treat each of these phases, so that people in the future, not just you even, but other researchers, can then look at those samples and probe through them, looking for triggers and possible markers of what is going on when and possibly why?
Andrew - Absolutely. And that's what I find really exciting about this study. It's about gathering new information and new insights into something that's not particularly well understood. So we will have a series of blood samples, as you say, taken over a period when the infection's completely asleep, when they've got no symptoms, no detectable signs, during early reawakening, and then fully awake. We'll treat this reawakened infection. We'll have this whole time series. We've already got lots of advanced tests and analysis planned. But you're right—there might be things in the future that we think of, and we'll have this wonderful resource of blood samples to explore further things that may not even be invented yet. It's really exciting.

07:43 - Kidney T cells subdue organ transplant rejection
Kidney T cells subdue organ transplant rejection
John Trowsdale, University of Cambridge
Since the first organ transplants were carried out over half a century ago, these surgeries have gone on to save thousands of lives. But with a few rare exceptions most transplants are still dogged by the fact that we’re introducing foreign tissue into the body, which usually provokes an immune response necessitating management with immune-suppressing drugs; which have side effects of course. But there is a way to transplant organs without needing to resort to immunosuppression. It was discovered over a decade ago that giving people a bone marrow transplant alongside a kidney from the same donor seemed to be able to reprogramme the immune system to accept the new tissue without rejecting it. But it didn’t work for other organs. Now a team in the US have made an extraordinary discovery: if you do a bone marrow transplant, and move in another organ, like a heart, but you also throw in a kidney for good measure, then it works. So there’s something special about the ability of the kidney to control immunity, and the team behind the work suspect it’s down to a family of immune regulating T cells that are common in the kidney. The findings have just been published in Science Translational Medicine, and we asked John Trowsdale, an immunologist at the University of Cambridge, to take a look at the paper for us…
John - Some people lose organs for various reasons and they need a donor organ. Now the problem though, it's not just a surgery, which is incredible. The immune system rejects any organ from another person that is genetically different to you. And so what clinicians try to do is to try to match, as far as they can, the tissue from the donor organ with the recipient. Even if you do match, quite often you've got to use certain drugs to suppress the immune system so it doesn't destroy the organ.
Chris - And there presumably are side effects of doing that because the immune system's there for a reason. So if we dial it down with these drugs, you're going to have potentially some comeback.
John - Absolutely. You can get more cancer with some of these drugs. And of course, because you're dampening down the immune system, you're more prone to infections.
Chris - So the ideal outcome would be if we could do these sorts of transplants but not need to do that to the immune system.
John - Absolutely. The alternative then is to perform a bone marrow transplant. In other words, you actually take the immune system from the donor at the same time that you take the organ. You effectively replace the bulk of the immune system with that of the donor. So in principle, it shouldn't recognise the organ when that's transplanted. What the recipient ends up with is a kind of chimera, if you like. That individual has the immune system of somebody else circulating in their blood.
Chris - And will this work for any organ?
John - Well, this is the key to this paper because they tried with the heart and they said, 'hold on a minute, we can do it for the kidney, but the heart gets rejected. Now why is that? I know, let's put in the kidney together with the heart and see what happens.' They did that double transplant. So they put the kidney and the heart in from the same donor at the same time and then, lo and behold, they found that the heart was not rejected.
Chris - So there's something special about a kidney being there that then makes it work for other organs?
John - There is, but there's one key issue I should mention. If you put in the kidney from one individual and a heart from a different individual, that heart is rejected. This is specific to the immune system from that one individual that's been donated.
Chris - There must be something about the kidney that it has the ability to reprogram the immune system or there's some other kind of cells in there which are doing something special in the kidney and they can come out and do the same job in the heart.
John - That's what the authors of this paper speculate. They suggest that there are some special cells in the kidney. They're called regulatory T cells and their role is to suppress the immune system. So the immune system is in a fine balance. There are the cells that attack organs or tumours and there are cells that actually suppress that. And they're in a fine balance and it appears that the, the kidney contains some cells that are these regulatory T cells and those regulatory T cells go through the body, through the blood and actually manage to condition the heart if you like, so that it actually is not rejected if you put the kidney in at the same time. But as I say, there's specificity here because if you put in a foreign heart, it gets rejected.
Chris - What is special about the kidney though? Because if they're just cells and they can go anywhere in the body, why do they have to be in a kidney to make them then come out and tell the body what to do with the heart?
John - Well, that's for the future and I think that this is obviously where this paper is heading. We want to know what the magic ingredient is so we can actually do this without undergoing all this surgery. With a kidney under heart. It's difficult enough to undergo heart surgery without having a kidney transplant as well. In fact, if you could get the cells from blood, as you say if they're everywhere, you might be able to Identify these cells from blood and put them IN at the same time. It'd be much more convenient.
Chris - Do you think there's something special about the kidney, that it's got some special structure in there we haven't discovered yet, or some other kind of cell that attracts, like a magnet, these special regulatory T cells and that's why the kidney's a particular focus? Or do you think there's something else going on that it is in some way controlling the immune system involving these cells, but there's something else special about the kidney? We haven't yet discovered what that is.
John - The short answer is I don't really know, I'm afraid. I think all those ideas that you propose are feasible. This study takes an awful long time. They waited five years to make sure those hearts were not rejected. What's also fascinating, I might add, is that they also found that you could graft skin from the donor to the recipient and it was not, in most cases, rejected. That's the holy grail of transplantation if you like. If you can take skin from one individual and transplant it to another and it's accepted, then that is quite remarkable. And so the tolerance they obtained in these experiments was profound. And if you can actually identify the cells responsible for that and manipulate those in future, I think that will save an awful lot of heartache for a number of people.

Weeing is contagious in chimpanzees
Ena Onishi, Kyoto University
Researchers in Japan have discovered a chimpanzee’s toilet routine is copied by others. The phenomenon - called “contagious urinations” - has been described in the journal Current Biology. Here’s Ena Onishi at Kyoto University…
Ena - We studied contagious urination in captive chimpanzees. In Japan, where I'm from, there is a term called 'Tsureshon,' which basically means urinating in the company of others. And it seems like that is very widespread across cultures. So we developed research questions from those moments when we saw chimpanzees urinating together.
Chris - This is a bit like one person gets up and says, I'm off for a wee, and then someone else says, oh yeah, I'll come too. It's that sort of one person does it and then others follow suit.
Ena - We first thought of Tsureshon, which is exactly what you mentioned, but actually the behaviour itself is a lot more like contagious yawning, for example, when one urinates another follows, but we don't know if that was intentional or not.
Chris - Where did you do the observations? What animals were you watching?
Ena - We did observation in Kumamoto Sanctuary of Kyoto University where I'm based at and I observed 20 chimpanzees.
Chris - So do you think the fact that they're in an artificial setting might have influenced this or do you think this is a realistic representation of what is happening in the wild as well?
Ena - There are some limitations about the captivity. For example, our study group had four groups of five individuals. The group composition isn't exactly like what it is in the wild setting because it's a much, much smaller group obviously. But thinking that this behaviour of contagious urination isn't something learned or something strategic, we think it's more of a natural thing that can happen without any intentional purposes. So we are pretty sure that it happens in the wild as well.
Chris - What actually happens then? What were the observations? You get one chimp wees and then everyone piles in and joins in. Is that how it works?
Ena - Just me just watching chimpanzees and recording all the urination and I also recorded their instance proximity, like the distance between each other and analysed if the chimpanzees in close proximity were more likely to follow the urination.
Chris - Do they go to a place to urinate or does one of them have a wee wherever they're standing and anyone who can see them then copies? Or do they get together in a group of wee in one place,
Ena - Usually chimpanzees don't go for a specific location for the urination, but I do see a tendency that they don't want to wet themselves with urine, so they might change their position or they might move slightly so that they can go to the edge of something and then urinate from the top. But usually they just urinate wherever they are.
Chris - Chimpanzees a bit like us have a really important social structure and a hierarchy, don't they? They have one who tends to be in charge and then there are underlings. So does it matter who urinates first and therefore who copies who or does it spread from anyone who starts urinating and then everyone follows suit?
Ena - At least in our study, we did not find specific social traits of the initiator, but what we found is for lower ranking individuals, they were more likely to follow anyone's urination.
Chris - The big question then is why they do this. Now with yawning, which you've already mentioned, we hypothesise that this is all about staying awake and if you've got one person feeling sleepy and they yawn, it makes sense to make everyone yawn and arouse themselves so that no one falls asleep. Why would contagious weeing happen? Why do this?
Ena - Honestly, we don't have like a single answer to it, but there are a couple interesting possibilities that might be useful. One idea is it could be useful for state matching of the group and state matching is a term used for syncing up the internal states of individuals and if they can achieve this through contagious urination, it could promote our maybe shared readiness for collective movements or just share physiological alignments so that they make group activities much smoother. And another possibility is that it could be something that's similar to chameleon effects, for example, where copying someone else's behaviour helps strengthen social bonding. I don't have any data for it, but still we do think that it's more widespread. It's not just captive chimpanzee behaviour, but it can probably be seen in other apes as well, or even more primates or other mammals.
Chris - And I understand, you know it's a pretty big day for you in terms of submission of your thesis.
Ena - Oh yes. <laugh>, I just submitted mine and hopefully it goes well. This study is one of the main chapters of my thesis.
Chris - So hopefully with a paper in one of the world's best biology journals, you should be in a good position to get your PhD
Ena - <laugh>. Thank you so much.

21:28 - 5 ways to reduce air travel's carbon footprint
5 ways to reduce air travel's carbon footprint
Mark Maslin, UCL
For those of us in the northern hemisphere, January is usually the time when we think about booking a holiday in warmer climes. However, for the most environmentally conscious of us at least, deciding whether to fly is usually a factor. Not only is it hugely expensive. But it also carries a big carbon footprint. UCL’s Mark Maslin has been writing about exactly that in The Conversation…
Mark - The aviation industry emits about 3% of global greenhouse gases. That's huge. But if you consider that concrete manufacturing is about 6% and actually 6% of oil production is actually used for manufacturing of plastics.
Chris - How does that compare, Mark, with say a data centre, the internet as a whole? Because we've got a huge investment and a big drive to use more AI and that sort of technology. That's incredibly processor hungry. So how does the internet stack up against aviation?
Mark - The big difficulty here is that you can have a data centre, or data centres, which are using huge amounts of electricity, but many companies are using renewable energy to make sure that they feed those hungry systems. So therefore you can have data centres that don't emit greenhouse gases or not very much. Whereas the aviation industry, we really do not have an alternative to aviation fuel or kerosene. Some of my competitors, you know, other universities are looking at 2040 and 2050, maybe hydrogen, maybe electric. But we don't have a solution now and that's why we set the centre up, the Center for Sustainable Aviation,. to look at solutions now we need to clean up the industry now to try and make it as sustainable as possible. So it joins the journey to net zero by 2050. There are so many things that we can do from engine manufacturing to building sustainable airports all the way through to the passenger experience, to how we actually fly the planes, all of which can contribute to reducing the amount of emissions that the industry produces.
Chris - Let's go through your recommendations then, because there are five of them. You've got a numbered list of these. What's number one?
Mark - So the first one is actually just planning where and how you fly your aeroplanes. If you actually optimise routes, firstly, you can reduce the amount of travel and therefore the amount of fuel you use. But also if you make sure the aircraft are perfectly lined up, they can land straight away. Because one of the real things that burns a huge amount of fuel is when of course the aircraft spins round and round for an hour, two hours, waiting for a landing spot. And of course this is where AI is gonna help to make sure that the planes don't get into traffic jams.
Chris - Are traffic jams a major contributor though? I'd never really thought about that. I know obviously there's a bit of stacking and that, but what fraction of the emissions then are just planes parked in the air effectively?
Mark - Well, unfortunately we really don't know because that sort of data isn't available. And this is why we are working very closely with the aviation industry and we're working with a very large number of airlines to say, look, give us your data. We'll find out. So you can then say, look, we have saved this amount.
Chris - What's number two?
Mark - Again, it's about making aeroplanes more efficient. So the really brand-new spanking-new aeroplanes are really efficient. They use all the tricks of aerodynamics to make sure that they use as less fuel as possible. But of course not all aeroplanes are like that. So we can retrofit older aeroplanes by making sure that they have sort of like winglets to reduce drag. We can improve sort of like how the cabins are actually sort of designed. And one of the interesting things is the weight distribution within an aeroplane. The biggest problem is you really want the weight at the back. You want the nose to be always being pulled up. The problem is we put the really heavy first class chairs or rooms in the front of the plane. So we need to actually think about how we design the inside of an aeroplane to make sure it's as efficient as possible.
Chris - And number three?
Mark - Ooh, this one is the switch to sustainable fuels. Now we can actually make synthetic fuels. So we can make artificial kerosene. You take water, you take CO2 out of the atmosphere and you use a shed load of renewable energy and you can create artificial fuel. But what we need to do is to share the SAFs fairly. We can't just have one airline going, Hey, we, we are cornering the market in SAFs and other airlines having to use sort of like normal kerosene. So we need sensible policies to bring in SAFs as quickly as possible. And of course it's about who has the know-how to actually be able to mix the SAFs into the normal fuels. So some airports already have invested in that technology and some haven't. And this actually may come to the next point which is point 4, which is about how do we make airports more eco-friendly? There are about 575 new airport projects around the world. So what we need to do is make sure that they are fully sustainable, make sure that they have all the actual technology that's needed to make sure that SAFs get onto the plane. Secondly, we make sure that all the airports run on renewable energy such as solar and wind. All those little vehicles that pull the food to the aeroplane that move the baggage around that even move the actual planes around. We need to make all of those electric as well so we can actually design airports which are eco-friendly and very, very efficient.
Chris - But what about being eco-friendly and very, very efficient to get to? Because the numbers that you are sighting capture the fact that you've got thousands of people in thousands of vehicle movements going to and from wherever they live to an airport that's all got a carbon footprint as well, surely.
Mark - Oh, thank you Chris. That's number five. Smart travel. We can rethink the passenger experience. And one of the biggest problems is we have people that start off at home with huge heavy bags. They then take a taxi or they take their car to the airport. Well, how about rethinking that? How about we have electric vans that go round for each flight and pick up all the baggage and efficiently take it to the airport. So all you have to do is take your hand luggage, get onto public transport, which hopefully is electric, and you get to the airport. We can also start thinking about whether you need to take your skis? Do you need to take your surfboard? Do you need to take the golf clubs with you? Do you need to take all of your toiletries and all the heavy stuff that you always have to take with you? Why not have those at the destination? So therefore people can pack a lot lighter. You probably have gone on those cut price airlines where they go, 'right, if you take a bag that's going to be an extra $40 or £40'. They're already trying to force passengers to think about weight.

29:32 - Could chewing gum exacerbate tinnitus?
Could chewing gum exacerbate tinnitus?
James - Thanks George. Tinnitus is a ringing, buzzing, or other perceptible sound in the ears that lacks an identifiable external acoustic source. It is a condition that affects millions of people worldwide, ranging from mild and occasional episodes to severe and chronic cases that significantly impact daily life. While the experience of tinnitus can vary greatly, it often shares one common feature: its underlying cause or causes are complex and, in many cases, difficult to pinpoint. It could be related to hearing loss, prolonged exposure to loud noises, certain medications, and medical conditions like high blood pressure or head injuries.
For a subset of people with tinnitus, however, their condition seems to be related to the somatosensory system.
Here to tell us more is Malcolm Hilton, an ear, nose and throat doctor, and associate professor of Extreme Medicine at the University of Exeter…
Malcolm - Thanks James. The somatosensory system is a part of the sensory nervous system. This complex network of neurons responds to changes at the surface of or inside the body. These changes can include movement, pressure, touch, temperature or pain.
Particularly relevant to somatosensory tinnitus, and, it sounds like, George’s case in particular, is the temporomandibular joint, or TMJ. This is the hinge connecting the jaw to the skull.
Temporomandibular somatosensory information is transported to the brain by the same neural fibres as project to the central auditory system. This enables the somatosensory system to influence the auditory system by altering spontaneous rates or synchrony of firing among neurons. In this way, the somatosensory system is able to alter the pitch or loudness of tinnitus.
James - In other words, George mentions his tinnitus becomes exacerbated by chewing a lot of gum, which might be straining his temporomandibular joint. Given the proximity of the part of the nervous system which deals with his jaw and some of the key parts involved with hearing, it’s conceivable that this is what’s leading to the somatosensory tinnitus.
Malcolm - Indeed, there is research linking temporomandibular disorders with a higher risk of tinnitus. It’s a curious phenomenon, but very interesting to hear about a possible case with such clear cut on/off symptoms like George’s.
Comments
Add a comment